| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.086 | 0.2 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |